(Q44520144)

3 December 2017

title

Lipodystrophy associated with protease inhibitors (English)

1 reference

3 December 2017

Panse I

1

1 reference

3 December 2017

Vasseur E

2

1 reference

3 December 2017

Raffin-Sanson ML

3

1 reference

3 December 2017

Staroz F

4

1 reference

3 December 2017

Rouveix E

5

1 reference

3 December 2017

Saiag P

6

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

British Journal of Dermatology

3 December 2017

published in

1 reference

3 December 2017

volume

142

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

496-500

1 reference

Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03363.X

Hypertrophy of the breasts in a patient treated with indinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03363.X

"Buffalo hump" in men with HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03363.X

Indinavir-associated lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03363.X

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03363.X

Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03363.X

Control of adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03363.X

Computed tomography and ultrasonography of the abdomen in congenital generalized lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03363.X

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03363.X

Lipodystrophy associated with nevirapine-containing antiretroviral therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03363.X

Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03363.X

10.1046/J.1365-2133.2000.03363.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference